Diurnal Group PLC (LON:DNL) insider Martin Whitaker acquired 3,703 shares of the business’s stock in a transaction dated Monday, November 27th. The stock was purchased at an average price of GBX 135 ($1.81) per share, with a total value of £4,999.05 ($6,694.86).

Martin Whitaker also recently made the following trade(s):

  • On Wednesday, November 8th, Martin Whitaker sold 33,650 shares of Diurnal Group stock. The stock was sold at an average price of GBX 135 ($1.81), for a total value of £45,427.50 ($60,837.69).

Shares of Diurnal Group PLC (LON:DNL) remained flat at $GBX 142.50 ($1.91) during mid-day trading on Wednesday. Diurnal Group PLC has a 1-year low of GBX 105 ($1.41) and a 1-year high of GBX 143 ($1.92).

Separately, Numis Securities restated a “buy” rating and set a GBX 169 ($2.26) target price on shares of Diurnal Group in a report on Wednesday, September 6th.

WARNING: This report was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/11/29/insider-buying-diurnal-group-plc-dnl-insider-buys-3703-shares-of-stock.html.

About Diurnal Group

Diurnal Group plc is a clinical-stage pharmaceutical company. The Company is engaged in developing hormone therapeutics to aid treatment for various endocrine conditions. The Company’s products include Chronocort, which is engaged in developing hydrocortisone product for the treatment of congenital adrenal hyperplasia and adrenal insufficiency; Infacort, which is engaged in creating paediatric hydrocortisone replacement product for neonates and infants suffering from adrenal insufficiency; Native Oral Testosterone, which is engaged in creating oral testosterone treatment for hypogonadism, and Tri4Combi, which is engaged in developing combination therapy product of thyroid hormones for patients suffering from hypothyroidism.

Receive News & Ratings for Diurnal Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diurnal Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.